ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Magilligan, D. J.
Right arrow Articles by Davila, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Magilligan, D. J., Jr
Right arrow Articles by Davila, J. C.

The Annals of Thoracic Surgery, Vol 24, 508-518, Copyright © 1977 by The Society of Thoracic Surgeons


ARTICLES

Bacteremia, endocarditis, and the Hancock valve

DJ Magilligan Jr, EL Quinn and JC Davila

Among 373 patients with porcine xenografts, there were 27 instances of exposure of the xenograft to bloodstream or endocardial infection in 22 patients. Nine patients underwent 10 separate insertions of xenografts for active infective endocarditis. There were no early infections or valve failures. Three patients returned with a late prosthetic valve endocarditis (PVE) due to a new infection. There were 6 instances of bacteremia early after xenograft valve insertion with no early infection, no valve dysfunction, and 1 instance of late PVE. Eleven patients had PVE on a porcine xenograft. Blood cultures in the 10 patients treated with antibiotics promptly became negative. There were 3 valve-related deaths: 2 from valve incompetence and 1 from mitral and aortic xenograft stenosis. Our experience suggests that the Hancock porcine xenograft is: (1) as resistant to infection as are rigid prostheses in active infective endocarditis; (2) resistant to early postoperative bacteremias; and (3) easier to sterilize than rigid prostheses and more durable than other tissue valves in the face of PVE.


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
S. M. Gordon, J. M. Serkey RN, T. F. Keys, T. Ryan, C. A. Fatica RN, S. K. Schmitt, J. A. Borsh RN, D. M. Cosgrove III, and J.-P. Yared
Secular Trends in Nosocomial Bloodstream Infections in a 55-Bed Cardiothoracic Intensive Care Unit
Ann. Thorac. Surg., January 1, 1998; 65(1): 95 - 100.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
U. Bortolotti, A. Milano, G. Thiene, and A. Mazzucco
Original expectations of the Hancock valve and 20 years of clinical reality
Eur. J. Cardiothorac. Surg., January 1, 1992; 6(suppl_1): S75 - S78.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1977 by The Society of Thoracic Surgeons.